Cargando…
The difference of T cell phenotypes in end stage renal disease patients under different dialysis modality
BACKGROUND: Impaired T cell immune function exists in end-stage renal disease (ESRD) patients. Dialysis treatment may lead to changes in T cell subsets. In the present study, we aimed to identify alterations of T cell phenotypes in ESRD patients, especially in those receiving peritoneal dialysis (PD...
Autores principales: | Xiaoyan, Jiao, Rongyi, Chen, Xuesen, Cao, Jianzhou, Zou, Jun, Ji, Xiaoqiang, Ding, Xiaofang, Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683494/ https://www.ncbi.nlm.nih.gov/pubmed/31383007 http://dx.doi.org/10.1186/s12882-019-1475-y |
Ejemplares similares
-
Premature aging of circulating T cells predicts all-cause mortality in hemodialysis patients
por: Xiang, Fangfang, et al.
Publicado: (2020) -
Educating end-stage renal disease patients on dialysis modality selection
por: Covic, Adrian, et al.
Publicado: (2010) -
Impact of dialysis modality on technique survival in end-stage renal disease patients
por: Lee, Jong-Hak, et al.
Publicado: (2016) -
The Burden of Cognitive Impairment in Patients With End-Stage Renal Disease and Impact on Dialysis Modality Choice
por: Jayanti, A., et al.
Publicado: (2016) -
Factors associated with the elevated percentage of CD4CD69 T cells in maintained hemodialysis patients
por: Chen, Rongyi, et al.
Publicado: (2017)